Novartis and Practical Applications of Aging Research for Drug Discovery forum
Good news!
"The dawn of aging pharmacology in Basel! Dr. Joerg Reinhardt, the chairman of the board of Novartis,
world's largest pharmaceutical company, delivered a powerful, engaging
and motivating talk to representatives of the drug discovery community
at all levels implicating aging as the most important focus area for the
future. His talk was predominantly focused on aging research and on
early success stories and ideas on how to bring novel geroprotectors to
market.
We salute Novartis and the many internal champions, who are
driving this to translate the blurry dream of healthy productive
longevity into abundant and tangible reality".
Dr.
Joerg Reinhardt, the chairman of the board of Novartis, world's largest
pharmaceutical company, delivered a powerful, engaging and motivating
talk to representatives of the drug discovery community at all levels
implicating aging as the most important focus area for the future.
No comments:
Post a Comment